Neumora Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:NMRA) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 316.97 M256.75 M223.82 M177.83 M191.05 M 負債合計 29.91 M28.38 M40.95 M45.67 M87.18 M 純資産合計 287.06 M228.36 M182.88 M132.16 M103.87 M 負債および純資産合計 316.97 M256.75 M223.82 M177.83 M191.05 M 有利子負債合計 ——39.45 M39.56 M114.53 M 純負債 ——-178.14 M-131.96 M-68 M

ニュース

Neumora Therapeutics: Downgrading After Navacaprant Development Setback (NASDAQ:NMRA)

Neumora Therapeutics, Inc. (NMRA) Q4 2025 Earnings Call Transcript

Neumora Therapeutics CFO Milliganが5119ドル相当の株式を売却

Neumora Therapeutics CFO Milligan sells $5119 in shares

Neumora Therapeutics, Inc. (NMRA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Slideshow (NASDAQ:NMRA) 2026-02-12

Intel, Wells Fargo among market cap stock movers on Tuesday

Oracle, Palantir among market cap stock movers on Monday

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio

リアリンク・パートナーズ、ニューモラ株をアウトパフォーム評価で開始

Leerink Partners initiates coverage on Neumora stock with Outperform rating

みずほ証券、ニューモラ・セラピューティクスの株式に「アウトパフォーム」評価を維持

Mizuho reiterates Outperform rating on Neumora Therapeutics stock